Dr. Krishna M. Sundar, MD
Sleep Medicine (Sleep Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 247
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Sleep Medicine (Internal Medicine) Physician primary
UT license 316489-1205 -
Critical Care Medicine (Internal Medicine) Physician
UT license 316489-1205 -
Internal Medicine Physician
UT license 316989 -
Pulmonary Disease Physician
UT license 316489-1205
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of California Davis Medical Center Sacramento, CA
Medical groups
- Regents of the Univ of Ca (1,584 clinicians)
- Regents of the University of California (567 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 247
- Services billed
- 420
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 116 | 84 |
| Sleep study including heart rate, breathing, airflow, and effort | 84 | 82 |
| Established patient office or other outpatient visit, 30-39 minutes | 72 | 61 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 50 | 50 |
| Sleep study in sleep lab (6 years or older) | 29 | 29 |
| New patient office or other outpatient visit, 45-59 minutes | 18 | 18 |
| New patient office or other outpatient visit, 30-44 minutes | 17 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Provo, UT | 22 |
| Zolpidem Tartrate Other prescribers in Provo, UT | 21 |
| Gabapentin Other prescribers in Provo, UT | 13 |
| Diazepam Other prescribers in Provo, UT | 12 |
| Eszopiclone Other prescribers in Provo, UT | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 6 payments worth $440 in total to this clinician.
| Takeda Pharmaceuticals U.S.A., Inc. | $192 |
|---|---|
| Inspire Medical Systems, Inc. | $150 |
| Harmony Biosciences LLC | $97.82 |
| Food and Beverage | $440 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $122,672 in research payments for these studies, mostly to the institutions running them.
- (OSPREY)Treating Obstructive Sleep APnea using TaRgetEd HYpoglossal Neurostimulation
Livanova USA, Inc. - OSPREY
Livanova USA, Inc. - A phase 3, 52-week, randomized, double-blind, placebo-controlled, para
GlaxoSmithKline, LLC.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.